Arcus Medical Receives Reimbursement Approval from the Prescription Pricing Authority in the United Kingdom

Share Article

Arcus Medical, LLC (Arcus), a leading innovator and manufacturer of patented medical devices, announced today that its āfex® brand of products for management of male incontinence has been approved for reimbursement by the Prescription Pricing Authority (PPA) in the United Kingdom.

Arcus Medical, LLC (Arcus), a leading innovator and manufacturer of patented medical devices, announced today that its āfex® brand of products for management of male incontinence has been approved for reimbursement by the Prescription Pricing Authority (PPA) in the United Kingdom.

Sales and distribution of āfex® products will be led by Mr. Darren Breen of iMEDicare, Ltd. in the UK. Since receiving CE Certification for āfex® in 2008, the UK market was selected as the strategic center for developing scalable sales and distribution channels to additional EU countries.

"We estimate that there are approximately 3 million men in the UK managing urinary incontinence. The market potential for āfex® in the UK is very compelling and we look forward to developing the UK market with iMEDicare," said Michael LaCount, President and CEO of Arcus Medical. "Since āfex® has been approved for reimbursement by the PPA, āfex® can compete with incumbent products primarily on the basis of innovation. We are confident that incontinent men in the UK will react very favorably to āfex® and we have every confidence that Mr. Breen can effectively build a robust strategic sales channel for āfex® in the UK."

Mr. Mark Miskie, Arcus founder and its Chief Operating Officer added, "Gaining PPA approval in the UK represents another significant milestone for Arcus Medical as we continue to build our core strategic capabilities and expand our global reach to help both patients and caregivers effectively manage incontinence every day."

About Arcus Medical
Arcus is dedicated to its mission of improving the quality of life and care for patients and their caregivers around the world. Since its founding in 2004, Arcus has advanced its pipeline of patented and proprietary medical device technologies for management of incontinence to the commercial markets. Arcus markets its innovative products under the āfex®, Folex®, and Provent™ brands.

The āfex® brand features a patented, non-adhesive receptacle that fits into a comfortable pair of cotton boxer-briefs and couples to a durable, secured collection bag offering an innovative and discreet solution for active, mobility-assisted, or sedentary men with incontinence.

Folex® branded products are specifically designed for extended, unobtrusive comfort and easy connection and release for patients using Foley catheters.

Provent™ branded briefs and pads feature a patented triple layer composite technology which offers superior ability to pull and lock wetness away from the skin while providing breathability for effective wetness protection.

For more information, please visit its website at http://www.arcusmedical.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael LaCount, Ph.D.
Visit website